Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • IdahoRAD
    Junior Member
    • Jan 2014
    • 9

    #1

    Annealing adapters

    Hello all--

    I work on preparing RAD libraries, and have a question regarding annealing adapters.

    Suppose my adapters' top and bottom oligos are each at a stock concentration of 100 uM. If I pool each adapter equi-molarly prior to annealing, will I have 100 uM of annealed adapter or will I have 200 uM of annealed adapter?

    Of course, I am simplifying my question, because the thing that is confusing me is the molarity-result of pooling equi-molarly. I have searched for an answer, to no avail! I know this is a basic question, but it has really been stumping me!

    Thank you,

    Cody
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    You will need concentrated annealing buffer to dilute your oligos for maximum annealing. In the simplest form if you just mix equal volume of 100 uM oligos you will get 50 uM adapters.

    Comment

    • IdahoRAD
      Junior Member
      • Jan 2014
      • 9

      #3
      Nucacidhunter--

      Thank you for your reply. Would you mind explaining your rationale, in the example you gave above? Is it because if we pool equi-molarly, we are doubling the volume and thus the molarity decreases?

      Suppose I pooled 100 umol of each component of the adapter, will I thus have 100 umol of annealed adapter?

      The person who was in charge of adapter preparations at my institution left rather abruptly, so I am trying to figure this out on my own. Seems like with these simple protocols, we (at UIdaho) take them for granted until we have to do them ourselves!

      Comment

      • nucacidhunter
        Jafar Jabbari
        • Jan 2013
        • 1250

        #4
        If X mole of oligo A and B is annealed (the same molar concentration) it will give X mole of adapter. In the process the volume has increased by 2x, so the concentration will decrease by 1/2x.

        Comment

        • kerplunk412
          Senior Member
          • Jun 2012
          • 119

          #5
          In case you are looking for second opinions, I completely agree with nucacidhunter.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 10:13 AM
          0 responses
          14 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          29 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          22 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Working...